A German follow-up long-term observation over 2 years in patients who had previously completed a clinical study to evaluate the effectiveness and safety of the TNF-alpha antibody infliximab in the treatment of patients with rheumatoid arthritis

被引:0
|
作者
Kalden, JR
Soerensen, H
Haentzschel, H
机构
[1] Univ Erlangen Nurnberg, Med Klin 3, D-8520 Erlangen, Germany
[2] Immanuel Krankenhaus, Berlin, Germany
[3] Univ Leipzig, Med Klin & Poliklin 4, D-7010 Leipzig, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:271 / 271
页数:1
相关论文
共 50 条
  • [1] Results of a German post-marketing surveillance study to evaluate the effectiveness and safety of the TNF-alpha antibody infliximab in the treatment of patients with rheumatoid arthritis
    Tony, H
    Kneitz, C
    Richter, C
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 272 - 272
  • [2] Long-term follow-up of patients treated with infliximab (anti-TNF alpha antibody) in clinical trials.
    Kavanaugh, A
    Schaible, T
    DeWoody, K
    Marsters, P
    Dittrich, K
    Harriman, G
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S401 - S401
  • [3] Long-term follow up: TNF-alpha blockers in the treatment of rheumatoid arthritis and psoriatic arthritis patients with chronic hepatitis-C infection
    Ince, A.
    Kamat, S.
    Ross, S. C.
    Weiss, T. D.
    Moore, T. L.
    Baldassare, A. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 322 - 322
  • [4] Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody
    Nishida, Keiko
    Okada, Yosuke
    Nawata, Masao
    Saito, Kazuyshi
    Tanaka, Yoshiya
    ENDOCRINE JOURNAL, 2008, 55 (01) : 213 - 216
  • [5] Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Attrition and long-term clinical effect
    Cruyssen, B. Vander
    Westhovens, R.
    Durez, P.
    Van den Bosch, F.
    Mielants, H.
    De Clerck, L.
    Peretz, A.
    Malaise, M.
    Verbruggen, L.
    Vastesaegere, N.
    Geldhof, A.
    De Keyser, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 349 - 349
  • [6] Long-term safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis: 3-year follow-up of a postmarketing surveillance
    Harigai, Masayoshi
    Tsuritani, Katsuki
    Yoshizawa, Yuri
    Atsumi, Tatsuya
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2022, 32 (03) : 508 - 516
  • [7] Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition.
    Cruyssen, Bert J. Vander
    Westhovens, Rene
    Durez, Patrick
    Van den Bosch, Filip
    Mielants, Herman
    De Clerck, Luc
    Peretz, Ann
    Malaise, Michel
    Verbruggen, Leon
    Vastesaeger, Nathan
    Geldhof, Anja
    De Keyser, Filip
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S234 - S235
  • [8] Long-Term Safety of Rituximab in Rheumatoid Arthritis: Pooled Analysis of Patients in Clinical Trials with up to 9.5 Years of Treatment
    van Vollenhoven, Ronald F.
    Emery, Paul
    Bingham, Clifton O.
    Keystone, Edward
    Fleischmann, Roy M.
    Furst, Daniel E.
    Tyson, Nicola
    Collinson, Neil
    Lehane, Patricia B.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S857 - S857
  • [9] Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study
    Hague, Wendy E.
    Simes, John
    Kirby, Adrienne
    Keech, Anthony C.
    White, Harvey D.
    Hunt, David
    Nestel, Paul J.
    Colquhoun, David M.
    Pater, Helen
    Stewart, Ralph A.
    Sullivan, David R.
    Thompson, Peter L.
    West, Malcolm
    Glasziou, Paul P.
    Tonkin, Andrew M.
    CIRCULATION, 2016, 133 (19) : 1851 - 1860
  • [10] Long-Term Safety and Efficacy of Olokizumab in Patients with Moderate-to-Severe Rheumatoid Arthritis Who Have Previously Failed Anti-TNF Treatment
    Genovese, Mark C.
    Fleischmann, Roy
    Tanaka, Yoshiya
    Furst, Daniel E.
    Yamanaka, Hisashi
    Joshi, Rajesh
    Zhu, Wei
    Shao, Jing
    Mashimo, Hideki
    Takeuchi, Tsutomu
    ARTHRITIS & RHEUMATOLOGY, 2015, 67